Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2015 60.31%
June 30, 2015 57.53%
March 31, 2015 48.81%
December 31, 2014 36.32%
September 30, 2014 42.44%
June 30, 2014 86.05%
March 31, 2014 35.01%
December 31, 2013 19.84%
September 30, 2013 37.02%
June 30, 2013 37.46%
March 31, 2013 51.69%
December 31, 2012 52.00%
September 30, 2012 53.95%
June 30, 2012 50.80%
March 31, 2012 38.01%
December 31, 2011 37.02%
September 30, 2011 42.21%
June 30, 2011 35.41%
March 31, 2011 43.46%
December 31, 2010 42.60%
September 30, 2010 61.67%
June 30, 2010 40.75%
March 31, 2010 44.67%
December 31, 2009 -3.84%
September 30, 2009 34.08%
Date Value
June 30, 2009 28.52%
March 31, 2009 24.54%
December 31, 2008 39.32%
September 30, 2008 28.47%
June 30, 2008 54.72%
March 31, 2008 10.50%
December 31, 2007 40.11%
September 30, 2007 -24.32%
June 30, 2007 -31.97%
March 31, 2007 92.12%
December 31, 2006 -9.76%
September 30, 2006 3.17%
June 30, 2006 -9.34%
March 31, 2006 -3.39K%
December 31, 2005
September 30, 2005 89.76%
June 30, 2005 -17.90%
March 31, 2005 22.81%
December 31, 2004 -1.11K%
September 30, 2004 -111.3%
June 30, 2004 -113.3%
March 31, 2004 -48.81%
December 31, 2003 29.24%
September 30, 2003 -85.11%
June 30, 2003 -52.41%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 55.48%
Bio-Rad Laboratories, Inc. 53.12%
Bruker Corp. 49.65%
Danaher Corp. 59.34%
Harvard Bioscience, Inc. 51.96%